Nicolas Ebel

Nicolas Ebel

UNVERIFIED PROFILE

Are you Nicolas Ebel?   Register this Author

Register author
Nicolas Ebel

Nicolas Ebel

Publications by authors named "Nicolas Ebel"

Are you Nicolas Ebel?   Register this Author

8Publications

421Reads

29Profile Views

JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease.

Clin Cancer Res 2013 Nov 30;19(22):6230-41. Epub 2013 Sep 30.

Authors' Affiliations: Disease Area Oncology and Preclinical Safety, Discovery and Investigative Pathology, Novartis Institutes for BioMedical Research, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0905DOI Listing
November 2013